Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 11/2020

01-11-2020 | Bariatric Surgery | Original Contributions

Insurance-Related Delay in Access to Bariatric Surgery, Is It Helpful as Is Thought?

Authors: Emiliano Domeniconi, Carlos Martin Esquivel, Manuel Garcia, Matias Sosa, Pablo Arias, Fernando Martínez Lascano, José María Foscarini

Published in: Obesity Surgery | Issue 11/2020

Login to get access

Abstract

Background

In Argentina, health insurances demand a 24-month duration preoperative weight loss program (POWLP) before bariatric surgery. It is unknown whether it enhances weight loss before or after surgery, or even if it is related to comorbidity remission. The main objective of this study was to determine its effectiveness and reliability.

Methods

An observational, longitudinal, retrospective study was carried out from June 2009 to December 2016, enrolling patients who underwent bariatric surgery in Sanatorio Allende Hospital of Cordoba, Argentina. Patients were divided into three groups according time-to-surgery from preoperative assessment initiation (A = before the 6th month, B = from 6th to 24th month, and C = over 24th month; all related to the first visit as previously mentioned). BMI, %EWL, comorbidity remission BMI, %EWL, comorbidity remission, and complications rate were assessed after surgery at 1, 3, 6, 12 months, and then annually until the 5th postoperative year. Revisional surgeries were excluded.

Results

Three hundred seventy-six patients were recruited. There were no significant differences in the preoperative and postoperative weight loss, neither co-morbidities resolution between groups.

Conclusions

Insurance-related delay in access to bariatric surgery is not associated to any benefit in comorbidity remission, as well as any improvement in weight loss in all groups studied.
Literature
1.
Lee AJ, Morgan CL, Morrissey M, et al. Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with type 1 diabetes, type 2 diabetes and with no diagnosed diabetes. Diabet Med. 2005 Nov;22(11):1482–6.
2.
Prospective Studies C, Whitlock G, Lewington S, et al. Body-mass index and cause- specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (London, England). 2009;373(9669):1083–96.CrossRef
3.
Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–24.CrossRef
4.
Kushner RF, Noble CA. Long-term outcome of bariatric surgery: an interim analysis. Mayo Clin Proc. 2006;81:S46–51.CrossRef
5.
Hammond RA, Levine R. The economic impact of obesity in the United States. Diabetes, metabolic syndrome and obesity. Diabetes Metab Syndr Obes. 2010;3:285–95.CrossRef
6.
JPH. Wilding. Treatment strategies for obesity. Obes Rev. 2007;(Suppl. 1):137–44.
7.
Hoerger TJ, Zhang P, Segel JE, et al. Cost- effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010;33(9):1933–9.CrossRef
8.
Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. Jama. 2008;299(3):316–23.CrossRef
9.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.CrossRef
10.
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.CrossRef
11.
Courcoulas AP, Yanovski SZ, Bonds D, et al. Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. JAMA surg. 2014;149(12):1323–9.CrossRef
12.
Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA surg. 2014;149(7):716–26.CrossRef
13.
Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. Jama. 2013;309(21):2240–9.CrossRef
14.
15.
Frezza EE. Six steps to fast-track insurance approval for bariatric surgery. Obes Surg. 2006;16:659–63. [PubMed: 16687038]CrossRef
16.
17.
18.
Tewksbury C, Williams NN, Dumon KR, et al. Preoperative medical weight management in bariatric surgery: a review and reconsideration. Obes Surg. 2017;27(1):208–14.CrossRef
19.
Jamal MK, DeMaria EJ, Johnson JM, et al. Insurance-mandated preoperative dietary counseling does not improve outcome and increases dropout rates in patients considering gastric bypass surgery for morbid obesity. Surg Obes Relat Dis. 2006;2(2):122–7.CrossRef
20.
Ochner CN, Puma LM, Raevouri A, et al. Effectiveness of a prebariatric surgery insurance-required weight loss egiment and relation to postsurgical weight loss. Obesity. 2010;18(2):287–92.CrossRef
21.
Kuwada TS, Richardson S, El Chaar M, et al. Insurance-mandated medical programs before bariatric surgery: do good things come to those who wait? Surg Obes Relat Dis. 2011;7(4):526–30.CrossRef
22.
Horwitz D, Saunders JK, Ude-Welcome A, et al. Insurance- mandated medical weight management before bariatric surgery. Surg Obes Relat Dis. 2016;12(3):496–9.CrossRef
23.
24.
25.
American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes 2018. Diabetes Care. 2018;41(Suppl. 1):S13–27.CrossRef
26.
27.
Venegas-Mariño M, Franco-Vélez A. Métodos diagnósticos en el síndrome de apnea-hipopnea obstructiva del sueño (SAHOS). Rev Fac Med. 2017;65(Sup):S91–5.CrossRef
28.
Brethauer SA, Julie Kim MD, Maher el Chaar MD, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11:489–506.CrossRef
29.
30.
Love KM, Mehaffey JH, Safavian D, et al. Bariatric surgery insurance requirements independently predict surgery dropout. Surg Obes Relat Dis. 2017;13:871–6.CrossRef
31.
Cohen RV, Luque A, Junqueira S, et al. What 739 is the impact on the healthcare system if access to bariatric surgery is delayed? Surg Obes Relat Dis. 2017;13(9):1619–27.CrossRef
32.
Al Harakeh AB, Burkhamer KJ, Kallies KJ, et al. Natural history and metabolic consequences of morbid obesity for patients denied coverage for bariatric surgery. Surg Obes Relat Dis. 2010;6(6):591–6.CrossRef
33.
34.
Alami RS, Morton JM, Schuster R, et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis. 2007;3(2):141–5. discussion 5–6CrossRef
35.
Cayci HM, Erdogdu UE, Karaman K, et al. Does weight gain during the operation wait time have an impact on weight loss after laparoscopic sleeve gastrectomy? Obes Surg. 2016;27(2):338–42.CrossRef
36.
Eisenberg D, Duffy AJ, Bell RL. Does preoperative weight change predict postoperative weight loss after laparoscopic roux-en-Y gastric bypass in the short term? J Obes. 2010;
37.
Still CD, Benotti P, Wood GC, et al. Outcomes of preoperative weight loss in high-risk patients undergoing gastric bypass surgery. Arch Surg. 2007;142(10):994–8. discussion 9CrossRef
38.
Schneider A et al. Postoperative outcomes in bariatric surgical patients participating in an insurance-mandated preoperative weight management program. Surg Obes Relat Dis. 14(5):623–30.
39.
Fris RJ. Preoperative low-energy diet diminishes liver size. Obes Surg. 2004;14:1165–70.CrossRef
40.
Diamant A, Cleghorn MC, Milner J, et al. Patient and operational factors affecting wait times in a bariatric surgery program in Toronto: a retrospective cohort study. CMAJ Open. 2015;3(3):E331–7.CrossRef
Metadata
Title
Insurance-Related Delay in Access to Bariatric Surgery, Is It Helpful as Is Thought?
Authors
Emiliano Domeniconi
Carlos Martin Esquivel
Manuel Garcia
Matias Sosa
Pablo Arias
Fernando Martínez Lascano
José María Foscarini
Publication date
01-11-2020
Publisher
Springer US
Published in
Obesity Surgery / Issue 11/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04794-9

Other articles of this Issue 11/2020

Obesity Surgery 11/2020 Go to the issue

Original Contributions

A Step in the Right Direction: Trends over Time in Bariatric Procedures for Patients with Gastroesophageal Reflux Disease

Original Contributions

Safety and Effectiveness of an Intragastric Balloon as an Adjunct to Weight Reduction in a Post-Marketing Clinical Setting

Multimedia Article

Surgical Management of Small Intestinal Bacterial Overgrowth After Roux-en-Y Gastric Bypass

Original Contributions

Safety and Efficacy of Bariatric Surgery in Advanced Liver Fibrosis

Correction

Correction to: The Procedureless Elipse Gastric Balloon Program: Multicenter Experience in 1770 Consecutive Patients

Original Contributions

Motivation and Weight Loss Expectations in Bariatric Surgery Candidates: Association with 1- and 2-Year Results After Bariatric Surgery